Chemoprotection by VEGF: Rationale for combination nab-paclitaxel and bevacizumab

被引：0
|
作者：
Trieu, V.
Ran, S.
Bivens, C.
Desai, N.
机构：
[1] Abraxis BioSci Inc, Los Angeles, CA USA
[2] Southern Illinois Univ, Sch Med, Springfield, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1064
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases
    Volk, Lisa D.
    Flister, Michael J.
    Chihade, Deena
    Desai, Neil
    Trieu, Vuong
    Ran, Sophia
    NEOPLASIA, 2011, 13 (04): : 327 - U167
  • [22] Nab-paclitaxel in patients with metastatic melanoma
    Leon-Ferre, Roberto A.
    Markovic, Svetomir N.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (12) : 1371 - 1377
  • [23] nab-Paclitaxel for the treatment of pancreatic cancer
    Kim, George
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 85 - 96
  • [24] nab-Paclitaxel mechanisms of action and delivery
    Yardley, Denise A.
    JOURNAL OF CONTROLLED RELEASE, 2013, 170 (03) : 365 - 372
  • [25] Gemcitabine and nab-paclitaxel drug interaction?
    Reactions Weekly, 2022, 1909 (1) : 9 - 9
  • [26] Metabolism of the taxanes including nab-paclitaxel
    Joerger, Markus
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (05) : 691 - 702
  • [27] NSCLC nab-Paclitaxel scores over conventional Paclitaxel
    PNEUMOLOGIE, 2015, 69 (08): : 496 - 496
  • [28] Phase I trial of combination nab-paclitaxel and pemetrexed in advanced solid tumors
    Ho, C.
    Davies, A. M.
    Lara, P. N.
    Chew, H. K.
    Beckett, L.
    Sangha, R. S.
    Mack, P. C.
    Gandara, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Evaluation of combination treatment benefits of nab-paclitaxel in experimental pancreatic cancer.
    Awasthi, Niranjan
    Ostapoff, Katherine
    Zhang, Changhua
    Schwarz, Margaret A.
    Schwarz, Roderich
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [30] nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer
    Megerdichian, Christine
    Olimpiadi, Yuliya
    Hurvitz, Sara A.
    CANCER TREATMENT REVIEWS, 2014, 40 (05) : 614 - 625
12345